168 related articles for article (PubMed ID: 23465317)
1. Anti-estrogenic activity of a human resveratrol metabolite.
Ruotolo R; Calani L; Fietta E; Brighenti F; Crozier A; Meda C; Maggi A; Ottonello S; Del Rio D
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1086-92. PubMed ID: 23465317
[TBL] [Abstract][Full Text] [Related]
2. Estrogen modulation properties of mangiferin and quercetin and the mangiferin metabolite norathyriol.
Wilkinson AS; Taing MW; Pierson JT; Lin CN; Dietzgen RG; Shaw PN; Gidley MJ; Monteith GR; Roberts-Thomson SJ
Food Funct; 2015 Jun; 6(6):1847-54. PubMed ID: 25940566
[TBL] [Abstract][Full Text] [Related]
3. The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells.
Maggiolini M; Recchia AG; Bonofiglio D; Catalano S; Vivacqua A; Carpino A; Rago V; Rossi R; Andò S
J Mol Endocrinol; 2005 Oct; 35(2):269-81. PubMed ID: 16216908
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol regulates the cell viability promoted by 17β-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor α and insulin growth factor-1 receptor in BG-1 ovarian cancer cells.
Kang NH; Hwang KA; Lee HR; Choi DW; Choi KC
Food Chem Toxicol; 2013 Sep; 59():373-9. PubMed ID: 23810794
[TBL] [Abstract][Full Text] [Related]
5. Glyphosate induces human breast cancer cells growth via estrogen receptors.
Thongprakaisang S; Thiantanawat A; Rangkadilok N; Suriyo T; Satayavivad J
Food Chem Toxicol; 2013 Sep; 59():129-36. PubMed ID: 23756170
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
7. Estrogenic activity of constituents from the rhizomes of Rheum undulatum Linné.
Park S; Kim YN; Kwak HJ; Jeong EJ; Kim SH
Bioorg Med Chem Lett; 2018 Feb; 28(4):552-557. PubMed ID: 29402747
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells.
Miksits M; Wlcek K; Svoboda M; Kunert O; Haslinger E; Thalhammer T; Szekeres T; Jäger W
Planta Med; 2009 Sep; 75(11):1227-30. PubMed ID: 19350482
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha.
Chakraborty S; Levenson AS; Biswas PK
BMC Struct Biol; 2013 Oct; 13():27. PubMed ID: 24160181
[TBL] [Abstract][Full Text] [Related]
11. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells.
Mueller SO; Simon S; Chae K; Metzler M; Korach KS
Toxicol Sci; 2004 Jul; 80(1):14-25. PubMed ID: 15084758
[TBL] [Abstract][Full Text] [Related]
12. The stilbenes resveratrol, pterostilbene and piceid affect growth and stress resistance in mammalian cells via a mechanism requiring estrogen receptor beta and the induction of Mn-superoxide dismutase.
Robb EL; Stuart JA
Phytochemistry; 2014 Feb; 98():164-73. PubMed ID: 24361291
[TBL] [Abstract][Full Text] [Related]
13. 2,3-cis-2R,3R-(-)-epiafzelechin-3-O-p-coumarate, a novel flavan-3-ol isolated from Fallopia convolvulus seed, is an estrogen receptor agonist in human cell lines.
Brennan JC; Denison MS; Holstege DM; Magiatis P; Dallas JL; Gutierrez EG; Soshilov AA; Millam JR
BMC Complement Altern Med; 2013 Jun; 13():133. PubMed ID: 23768005
[TBL] [Abstract][Full Text] [Related]
14. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
Wietzke JA; Welsh J
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the potential activity of major dietary compounds as selective estrogen receptor modulators in two distinct cell models for proliferation and differentiation.
Lecomte S; Lelong M; Bourgine G; Efstathiou T; Saligaut C; Pakdel F
Toxicol Appl Pharmacol; 2017 Jun; 325():61-70. PubMed ID: 28396216
[TBL] [Abstract][Full Text] [Related]
16. Glucuronidation does not suppress the estrogenic activity of quercetin in yeast and human breast cancer cell model systems.
Ruotolo R; Calani L; Brighenti F; Crozier A; Ottonello S; Del Rio D
Arch Biochem Biophys; 2014 Oct; 559():62-7. PubMed ID: 24657077
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of resveratrol sensitivities and metabolic patterns in human and rat glioblastoma cells.
Sun Z; Shi S; Li H; Shu XH; Chen XY; Kong QY; Liu J
Cancer Chemother Pharmacol; 2013 Nov; 72(5):965-73. PubMed ID: 23989725
[TBL] [Abstract][Full Text] [Related]
18. Transport, deglycosylation, and metabolism of trans-piceid by small intestinal epithelial cells.
Henry-Vitrac C; Desmoulière A; Girard D; Mérillon JM; Krisa S
Eur J Nutr; 2006 Oct; 45(7):376-82. PubMed ID: 17009167
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
[TBL] [Abstract][Full Text] [Related]
20. Quantitative structure-antioxidant activity relationship of trans-resveratrol oligomers, trans-4,4'-dihydroxystilbene dimer, trans-resveratrol-3-O-glucuronide, glucosides: trans-piceid, cis-piceid, trans-astringin and trans-resveratrol-4'-O-beta-D-glucopyranoside.
Mikulski D; Molski M
Eur J Med Chem; 2010 Jun; 45(6):2366-80. PubMed ID: 20199826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
